Strategies to improve diversity, equity, and inclusion in clinical trials

There is a growing need for diversity, equity, and inclusion (DEI) in cancer care, particularly with respect to equal access and accrual to clinical trials. This commentary describe steps taken to address disparities in the authors' own clinical practice and proposes actions at the patient, provider, community, and institution levels to improve DEI in clinical trials.

Automated summary

This commentary addresses the growing need for diversity, equity, and inclusion (DEI) in cancer care, particularly in relation to equal access and accrual to clinical trials. The authors describe steps taken in their own clinical practice and propose actions at various levels to improve DEI in clinical trials.